Aron_lavender
New Member
- Joined
- Mar 15, 2021
- Messages
- 1
- Office Version
- 2019
- Platform
- Windows
Hi, I have a text file containing information of journal articles. The articles are numbered (as 1. 2. 3.) and within each article there are other items (as Background: Author information: DOI: PMID: ). The text file is not formatted perfectly as the first 3 items do not have a name tag like others (eg DOI
These lines contain information about the article issue number, article title, and author names.
My objective is to get a dataset by extracting the 7 items into columns:
1) article issue number, 2) article title, 3) author information, 4) All lines between items 3 and 5, 5) DOI, 6)PMCID, 7)PMID
There are about 100 articles, so I am pasting the first 2 below.
I'd be very grateful if you can provide me with some hints to do this.
Thank you!
------------------------------------------------
1. BMC Cardiovasc Disord. 2020 Jan 7;20(1):1. doi: 10.1186/s12872-019-01312-3.
Advances in transcatheter mitral and tricuspid therapies.
Overtchouk P(1)(2), Piazza N(2), Granada J(3), Soliman O(4)(5), Prendergast
B(6), Modine T(7)(8).
Author information:
(1)Department of Cardiology, University Hospital of Bern, Bern, Switzerland.
(2)Interventional cardiology, McGill University Health Centre, 1001 Boulevard
Décarie, Montréal, QC, H4A 3J1, Canada.
BACKGROUND: While rheumatic mitral stenosis has been effectively treated
percutaneously for more than 20 years, mitral and tricuspid regurgitation
treatment appear as a contemporary unmet need. The advent of transcatheter
therapies offer new treatment options to often elderly and frail patients at
high risk for open surgery. We aimed at providing an updated review of
fast-growing domain of transcatheter mitral and tricuspid technology.
CONCLUSION: The future appears bright for transcatheter mitral therapies, albeit
their place in clinical practice is yet to be clearly defined. Tricuspid
transcatheter therapies might address the unmet need of tricuspid regurgitation
treatment.
DOI: 10.1186/s12872-019-01312-3
PMCID: PMC6945613
PMID: 31910809 [Indexed for MEDLINE]
Conflict of interest statement: Dr. Thomas Modine is a consultant for Boston
Scientific, Medtronic, Edwards, Cephea, Microport, GE, Abbott; he received a
research support grant from Edwards. Dr. Nicolo Piazza declares to be
consultant/proctor for HighLife, Medtronic and MicroPort, and is a consultant
for Cephea. Dr. Juan Granada received Grant/Research Support by Abbott Vascular,
Amaranth Medical, Angiometrix, AstraZeneca, Bioventrix, Boston Scientific,
Caliber Therapeutics, Cardia, Cardiac Implants, Cagent, Cardiovascular Systems
Inc., Cardiosolutions, Celladon, Cephea, Circulite/Heartware, ControlRad,
CorindusVascular Robotics, CR Bard/Lutonix, DC Devices, Direct Flow Medical,
Draper, Edwards LifeSciences, FulgurMedical, Guided Delivery Systems, Intact
Vascular, Lutonix, Marvel Medical, Medtronic, Mercator, MedAlliance, MerilLife
Sciences, Microvention, MicroInterventionalSystems, Mitralign, Neovasc,
Nitiloop, Nitinotes, OrbusNeichMedical, REVA Medical, Siemens, Sonivie,
Spectranetics, Svelte, Stentys, Surmodics, Thoratec, UniQure, Volcano, WL Gore,
Zenvalve. Equity Position/Consulting in Cephea. Pavel Overtchouk declares no
conflict of interest related to the presented work.
2. Singapore Med J. 2013 Oct;54(10):538-51. doi: 10.11622/smedj.2013197.
Advances in rehabilitation medicine.
Ng YS(1), Chew E, Samuel GS, Tan YL, Kong KH.
Author information:
(1)Department of Rehabilitation Medicine, Singapore General Hospital, Outram
Road, Singapore 169608. ng.yee.sien@sgh.com.sg.
Rehabilitation medicine is the medical specialty that integrates rehabilitation
as its core therapeutic modality in disability management. More than a billion
people worldwide are disabled, and the World Health Organization has developed
the International Classification of Functioning, Disability and Health as a
framework through which disability is addressed. Herein, we explore paradigm
shifts in neurorehabilitation, with a focus on restoration, and provide
overviews on developments in neuropharmacology, rehabilitation robotics, virtual
reality, constraint-induced therapy and brain stimulation. We also discuss
important issues in rehabilitation systems of care, including integrated care
pathways, very early rehabilitation, early supported discharge and
telerehabilitation. Finally, we highlight major new fields of rehabilitation
such as spasticity management, frailty and geriatric rehabilitation, intensive
care and cancer rehabilitation.
DOI: 10.11622/smedj.2013197
PMID: 24154577 [Indexed for MEDLINE]
These lines contain information about the article issue number, article title, and author names. My objective is to get a dataset by extracting the 7 items into columns:
1) article issue number, 2) article title, 3) author information, 4) All lines between items 3 and 5, 5) DOI, 6)PMCID, 7)PMID
There are about 100 articles, so I am pasting the first 2 below.
I'd be very grateful if you can provide me with some hints to do this.
Thank you!
------------------------------------------------
1. BMC Cardiovasc Disord. 2020 Jan 7;20(1):1. doi: 10.1186/s12872-019-01312-3.
Advances in transcatheter mitral and tricuspid therapies.
Overtchouk P(1)(2), Piazza N(2), Granada J(3), Soliman O(4)(5), Prendergast
B(6), Modine T(7)(8).
Author information:
(1)Department of Cardiology, University Hospital of Bern, Bern, Switzerland.
(2)Interventional cardiology, McGill University Health Centre, 1001 Boulevard
Décarie, Montréal, QC, H4A 3J1, Canada.
BACKGROUND: While rheumatic mitral stenosis has been effectively treated
percutaneously for more than 20 years, mitral and tricuspid regurgitation
treatment appear as a contemporary unmet need. The advent of transcatheter
therapies offer new treatment options to often elderly and frail patients at
high risk for open surgery. We aimed at providing an updated review of
fast-growing domain of transcatheter mitral and tricuspid technology.
CONCLUSION: The future appears bright for transcatheter mitral therapies, albeit
their place in clinical practice is yet to be clearly defined. Tricuspid
transcatheter therapies might address the unmet need of tricuspid regurgitation
treatment.
DOI: 10.1186/s12872-019-01312-3
PMCID: PMC6945613
PMID: 31910809 [Indexed for MEDLINE]
Conflict of interest statement: Dr. Thomas Modine is a consultant for Boston
Scientific, Medtronic, Edwards, Cephea, Microport, GE, Abbott; he received a
research support grant from Edwards. Dr. Nicolo Piazza declares to be
consultant/proctor for HighLife, Medtronic and MicroPort, and is a consultant
for Cephea. Dr. Juan Granada received Grant/Research Support by Abbott Vascular,
Amaranth Medical, Angiometrix, AstraZeneca, Bioventrix, Boston Scientific,
Caliber Therapeutics, Cardia, Cardiac Implants, Cagent, Cardiovascular Systems
Inc., Cardiosolutions, Celladon, Cephea, Circulite/Heartware, ControlRad,
CorindusVascular Robotics, CR Bard/Lutonix, DC Devices, Direct Flow Medical,
Draper, Edwards LifeSciences, FulgurMedical, Guided Delivery Systems, Intact
Vascular, Lutonix, Marvel Medical, Medtronic, Mercator, MedAlliance, MerilLife
Sciences, Microvention, MicroInterventionalSystems, Mitralign, Neovasc,
Nitiloop, Nitinotes, OrbusNeichMedical, REVA Medical, Siemens, Sonivie,
Spectranetics, Svelte, Stentys, Surmodics, Thoratec, UniQure, Volcano, WL Gore,
Zenvalve. Equity Position/Consulting in Cephea. Pavel Overtchouk declares no
conflict of interest related to the presented work.
2. Singapore Med J. 2013 Oct;54(10):538-51. doi: 10.11622/smedj.2013197.
Advances in rehabilitation medicine.
Ng YS(1), Chew E, Samuel GS, Tan YL, Kong KH.
Author information:
(1)Department of Rehabilitation Medicine, Singapore General Hospital, Outram
Road, Singapore 169608. ng.yee.sien@sgh.com.sg.
Rehabilitation medicine is the medical specialty that integrates rehabilitation
as its core therapeutic modality in disability management. More than a billion
people worldwide are disabled, and the World Health Organization has developed
the International Classification of Functioning, Disability and Health as a
framework through which disability is addressed. Herein, we explore paradigm
shifts in neurorehabilitation, with a focus on restoration, and provide
overviews on developments in neuropharmacology, rehabilitation robotics, virtual
reality, constraint-induced therapy and brain stimulation. We also discuss
important issues in rehabilitation systems of care, including integrated care
pathways, very early rehabilitation, early supported discharge and
telerehabilitation. Finally, we highlight major new fields of rehabilitation
such as spasticity management, frailty and geriatric rehabilitation, intensive
care and cancer rehabilitation.
DOI: 10.11622/smedj.2013197
PMID: 24154577 [Indexed for MEDLINE]
